Eli Lilly and Company
LLY
$1,189.41
-$44.25-3.59%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 16.04% | 2.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.04% | 2.63% | |||
| Cost of Revenue | -8.64% | 6.09% | |||
| Gross Profit | 21.48% | 1.90% | |||
| SG&A Expenses | 16.91% | -15.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.95% | -5.74% | |||
| Operating Income | 27.40% | 12.89% | |||
| Income Before Tax | 4.49% | 7.06% | |||
| Income Tax Expenses | 48.01% | -10.72% | |||
| Earnings from Continuing Operations | -4.07% | 11.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.07% | 11.42% | |||
| EBIT | 27.40% | 12.89% | |||
| EBITDA | 26.29% | 11.25% | |||
| EPS Basic | -3.84% | 11.86% | |||
| Normalized Basic EPS | 31.33% | 9.65% | |||
| EPS Diluted | -3.87% | 11.75% | |||
| Normalized Diluted EPS | 31.34% | 9.47% | |||
| Average Basic Shares Outstanding | -0.23% | -0.39% | |||
| Average Diluted Shares Outstanding | -0.25% | -0.23% | |||
| Dividend Per Share | 0.00% | 15.33% | |||
| Payout Ratio | 0.04% | 0.03% | |||